Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
VACC Vaccitech
3.040+0.055+1.84%
Trading Session
02/08 11:52 ET
High
3.230
Open
3.230
Turnover
45.05K
Low
3.030
Pre Close
2.985
Volume
14.43K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Analysts' Top Healthcare Picks: Replimune Group (REPL), Vaccitech Plc (VACC)
Vaccitech Appoints Industry Veteran, Nadège Pelletier, Ph.D., as Chief Scientific Officer
Dr. Pelletier joins leadership team to continue the advancement of Vaccitech's diverse clinical pipeline and partnerships, bringing more than 15 years' experience in pharmaceuticals and academia in immunology and
12 Health Care Stocks Moving In Friday's After-Market Session
GainersVaccitech (NASDAQ:VACC) shares rose 8.5% to $3.2 during Friday's after-market session. The company's market cap stands at $119.3 million. Calithera Biosciences (NASDAQ:CALA) shares rose 7.34% t
A Look Into Healthcare Sector Value Stocks
What Defines a Value Stock?A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investo
Overview Of Value Stocks In The Healthcare Sector
What is a Value Stock?A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors ar
Vaccitech (NASDAQ:VACC) Trading 0.4% Higher
Shares of Vaccitech plc (NASDAQ:VACC – Get Rating) shot up 0.4% during mid-day trading on Friday . The stock traded as high as $2.49 and last traded at $2.46. 35,486 shares traded hands during tradin
Wall Street Gains Support American Depositary Receipts of European Equities
11:12 AM EST, 12/29/2022 (MT Newswires) -- Early gains in US markets were propping up American depository receipts of European stocks, with the S&P Europe Select ADR Index up 1.2% at 1,100.34 in Thurs
Looking Into Vaccitech's Return On Capital Employed
Pulled from Benzinga Pro data, Vaccitech (NASDAQ:VACC) posted Q3 earnings of $8.22 million, an increase from Q2 of 47.6%. Sales dropped to $6.17 million, a 63.87% decrease between quarters. Vaccitech
Vaccitech (NASDAQ:VACC) Stock Price Down 2.2%
Vaccitech plc (NASDAQ:VACC – Get Rating) traded down 2.2% on Wednesday . The company traded as low as $2.18 and last traded at $2.25. 30,744 shares changed hands during mid-day trading, a decline of
Vaccitech to Hold a KOL Webinar
Company Overview
More
Vaccitech Plc operates as a holding company. It is engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. The company was founded in March 2021 and is headquartered in Oxford, the United Kingdom.
CEO： Mr. William J. Enright
Market： NASDAQ
Listing Date： 04/30/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet